Articles tagged with Multiple Sclerosis
A novel naked DNA vaccination technology has been developed to overcome autoimmune diseases like rheumatoid arthritis and multiple sclerosis. The vaccine introduces engineered genes that neutralize proinflammatory peptides, allowing the immune system to self-regulate its response and prevent disease progression.
Researchers found that a 200 milligram-per-day dose of the narcolepsy drug modafinil successfully controlled fatigue in patients with MS, a disease that attacks the nervous system. The study involved 72 patients with severe fatigue and MS, who reported significantly less fatigue when taking the 200 mg dose compared to the placebo.
A new drug, modafinil, has been shown to effectively treat fatigue in multiple sclerosis patients, with over 85% of participants able to identify the active ingredient. The study found that modafinil improved fatigue severity and had minimal side effects, making it a promising first-line treatment for MS patients.
Researchers at Emory University have uncovered a significant connection between mast cells and the development of multiple sclerosis. Mast cells, previously only studied in respiratory tract diseases like hay fever and asthma, are now linked to nerve damage in MS.
Researchers from Clemson University and UK scientists found that synthetic cannabinoids reduce spasticity and tremor in a mouse model of multiple sclerosis. The discovery may lead to treatments without psychoactive side effects.
Patients with secondary progressive multiple sclerosis treated with Novantrone experienced a sustained reduction in their number of attacks and delay in disability progression compared to those treated with placebo. The treatment resulted in generally manageable side effects and a smaller number of relapses in the third year.
University of Illinois scientists have discovered that steroids can increase myelin synthesis, reversing a major problem in multiple sclerosis and other demyelinating diseases. The findings offer new potential treatments for nerve injuries and demyelinating diseases.
Researchers have found that fatty acids from various plants and fungi can prevent MS-like symptoms in animal models. Dr Harbige's team thinks certain fatty acids work by dampening the immune system's damaging effects, but more rigorous clinical trials are needed to confirm.
A study by the National Institute of Neurological Disorders and Stroke found that more than 70% of MS patients exhibited an increased immune response to human herpes virus-6, suggesting a potential trigger for the disease. Active HHV-6 was detected in approximately 35% of all MS patients studied.
Researchers found that only three of 39 physicians ordered an MRI for a patient with low yield, while others suggested it in the future or referred her to a neurologist. Physicians often failed to use recommended communication skills, such as asking about the patient's friend's experience with MS.
Scientists at the University of Wisconsin-Madison have successfully transplanted nervous system cells into dogs with diseased spinal cords, achieving significant myelination and growth. This breakthrough finding offers new hope for multiple sclerosis treatment and may be applicable to other demyelinating disorders.